Handelsbanken Fonder’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,500
Closed -$75K 1703
2022
Q1
$75K Hold
11,500
﹤0.01% 1691
2021
Q4
$188K Hold
11,500
﹤0.01% 1717
2021
Q3
$334K Hold
11,500
﹤0.01% 1562
2021
Q2
$399K Sell
11,500
-70,200
-86% -$2.23M ﹤0.01% 1530
2021
Q1
$2.58M Buy
81,700
+75,000
+1,119% +$3.05M 0.01% 557
2020
Q4
$317K Buy
+6,700
New +$311K ﹤0.01% 1380

Other funds holding ZYME

Handelsbanken Fonder's ZYME Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 11,500 shares — an estimated $75K sold.

Handelsbanken Fonder first reported a position in ZYME in Q4 2020 and held it in 6 quarters. The position peaked at $2.58M in Q1 2021. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 11,500 Zymeworks shares in Q2 2022, an estimated $75K.
  • Handelsbanken Fonder first reported a position in Zymeworks in Q4 2020 and held it in 6 quarters.
  • Handelsbanken Fonder's Zymeworks position peaked at $2.58M in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.